Insider Transactions Reported by 5 Insiders of INTERPACE BIOSCIENCES, INC.

Symbol
IDXG on OTC
Location
Parsippany, NJ

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

INTERPACE BIOSCIENCES, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ampersand 2018 Limited Partnership 10%+ Owner $27,999,999 20 Jan 2026
1315 Capital II, L.P. 10%+ Owner $19,000,000 20 Jan 2026
Christopher McCarthy Chief Financial Officer $94,518 01 Feb 2024
Thomas W. Burnell President & CEO, Director 21 May 2021
Vijay Aggarwal Director 01 Feb 2022

Recent Insider Transactions by Companies or Individuals for INTERPACE BIOSCIENCES, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
1315 Capital II, L.P. IDXG Common Stock Conversion of derivative security 9,405,941 9,405,941 20 Jan 2026 Direct
1315 Capital II, L.P. IDXG Series C Convertible Preferred Stock Conversion of derivative security -100% -19,000 0 20 Jan 2026 Direct
Ampersand 2018 Limited Partnership IDXG Common Stock Conversion of derivative security 13,861,386 13,861,386 20 Jan 2026 Direct
Ampersand 2018 Limited Partnership IDXG Series C Convertible Preferred Stock Conversion of derivative security -100% -28,000 0 20 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.